ImmunityBio, Inc. IBRX
At closeNov 11, 2026, 7:48 PM EST
After hours · Nov 11, 7:48 PM ET
- YTD
- +236.87%
- 1 year
- +211.68%
Discussion (3500)
Sign in to join the discussion
IBRX is not a biotech spec has FDA approval and sales and growing now. Basically worldwide use for a bladder cancer and soon for all bladder cancer. What next? More FDA applications for other uses. NK T cell production and NK killer T cell infusions and sales. Anktiva has the potential to be used alone or in combination for all cancers. Now add in to treat Lymphopenia and sepsis and maybe cure AIDS too. Not treat AIDS but cure AIDS.
The future is only up up up for IBRX Immunitybio
Additional FDA application for uses soon too. Maybe announce positive results eliminating AIDS virus from the infected. Ok that one would rocket us to the stars if the media covers it.
Wow and what if Anktiva clears AIDS virus from the bodies of the infected. A cure for AIDS. AIDS therapy is over 50 billion a year every year.
And a M240 machine gun too for Xmas
I want a G550 for Christmas
Let's hope Dr PSS is on CNBC or FoxB tomorrow
What's the tail number on his G550
Mr mullaly
Omg your post was hilarious lmao
It's infuriating that the FDA is slow playing ImmunityBio and letting people die lose and
their bladders.
Anktiva should be available for all indications and combinations with other treatments.
Dementia meds don't work and cost a fortune. What good is it if your brain is 6-10% less stupid after 10 years. Hello you are still stupid
Tre you are a fool
Dr. PSS is building a BP company that's focused on cures not treatments and repeat business RXs forever how novel.
If Anktiva can clear the AIDS virus, big pharma will lose 50-60 billion in sales annually treating AIDS. Why they never cure AIDS only treat manage and it's meds forever.
